Clinical trial

Clinical Validation of mμSORS for Noninvasive Blood Glucose Detection

NCT05504005

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Multi-channel Microspatial Offset Raman Scattering Spectroscopy (mμSORS) for Noninvasive Blood Glucose Detection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Validation of mμSORS for Noninvasive Blood Glucose Detection

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-08

PhaseNA

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Medical Deviceunresolved

Interventions

Multi-channel Microspatial Offset Raman Scattering Spectroscopy (mμSORS) for Noninvasive Blood Glucose DetectionDEVICE

Sponsors & collaborators

Shanghai Jiao Tong University School of Medicinelead sponsor

Shanghai Photonic View Technology Co., Ltd.collaborator

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05504005 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.